Karim Lalji is the founder of Microbion. Microbion has raised $2M in total funding. Latest round: Series A. Based in Bozeman, USA.
Karim Lalji is the CEO of Microbion Pharma Corp. The company, Microbion Corporation, specializes in developing anti-infective drugs and recently received up to $2.1 million in non-dilutive funding from the US Navy through the Medical Technology Enterprise Consortium (MTEC) partnership. This funding is to advance topical pravibismane for diabetic foot ulcer infection.
Full founder directory · Investor directory · Company funding database · Fundraising library